Defeating Alzheimer's Moderator: 
Dr. Rudolph E. Tanzi, Professor of Neurology, Harvard Medical School, Director, Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Diseases Speakers:
Tim Armour, President and CEO, Cure Alzheimer's Fund
Kiran Reddy, Principal, Third Rock Ventures
 Ken Rhodes, President, Discovery Neurobiology at Biogen Idec 
Dan Skovronsky, Founder and CEO, Avid Radiopharmaceuticals
|
|
| Alzheimer's Disease devastates the lives of 25-40 million people worldwide - a number that is projected to quadruple in the coming decades. There are currently no FDA-approved medicines that can significantly modify the course of the disease. There is no effective means for early detection and diagnosis. Furthermore, neurodegeneration is among the mostly costly and risky areas of drug development. Yet, the high risk is balanced by high reward, and today Alzheimer's is both an area of tremendous scientific promise and an exciting business opportunity. As companies of all sizes make significant commitments to neurodegeneration, researchers have made breathtaking progress in understanding the disease mechanism. At this event we'll hear from a person leading the charge - Dan Skovronsky from Avid Radiopharmaceuticals, a startup that recently sold for over $300 million Dan will head an all-star panel of those engaged in funding, supporting and conducting R&D efforts in academia, industry and startups. Together they'll provide a full 360 view of the Alzheimer's battle. Date: December 14, 2011 Time: Registration & snacks begins at 5:30, Event at 6:15 , Networking reception after the event, from 8:00-9:00pm, in the R&D Pub, Stata Center 4th Floor Location: MIT Stata Center, 32 Vassar Street, Kirsch Auditorium Cambridge, MA Pricing: Forum Members: $25 , Non-members $50, full-time students are free with a valid ID Event organizer: Ben Zeskind, PhD, MBA, Co-Founder and Chief Executive Officer, Immuneering Corp |
Upcoming Innovation Series Event | Feb, 8, 2012 The Future of the Personal Genome Speakers: Dr. George Church of The Personal Genome Project
Colin Hill, CEO, Co-Founder and President, GNS Healthcare
Jamie Heywood, Co-Founder and Chairman, PatientsLikeMe
Dr. Michael Pellini, President and CEO, Foundation Medicine Moderating the panel will be Dr. Kevin Davies, Editor-in-Chief, Bio-IT World |
|
|
